Mark Taylor
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 12
- Spectroscopy 10
- Mass Spectrometry Techniques and Applications 5
- Analytical Chemistry and Chromatography 4
- Co-authors
- Wolfgang R. Dostmann (2 shared papers)Werner Tegge (2 shared papers)Christian K. Nickl (2 shared papers)Ronald Frank (2 shared papers)Joseph E. Brayden (2 shared papers)Felician Muntean (4 shared papers)Anne B. McCoy (4 shared papers)W. C. Lineberger (4 shared papers)
- Journals
- The Journal of Chemical Physics (3 papers)Neurology (2 papers)Amyloid (2 papers)The Journal of Physical Chemistry A (2 papers)Frontiers in Cardiovascular Medicine (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Taylor
37 papers receiving 919 citations
Mark Taylor's Hit Papers
Peers
Comparison fields: 5 of 105
- Nephrology 168
- Genetics 81
- Molecular Biology 441
- Spectroscopy 95
- Physical and Theoretical Chemistry 49
Countries citing papers authored by Mark Taylor
This map shows the geographic impact of Mark Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Taylor more than expected).
Fields of papers citing papers by Mark Taylor
This network shows the impact of papers produced by Mark Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Taylor. The network helps show where Mark Taylor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Taylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial Hit paper breakdown → | 2022 | 218 |
| 2 | 2000 | 133 | |
| 3 | 2009 | 119 | |
| 4 | 2011 | 49 | |
| 5 | 2007 | 40 | |
| 6 | 1998 | 40 | |
| 7 | 1998 | 39 | |
| 8 | 2004 | 39 | |
| 9 | 2004 | 38 | |
| 10 | 2002 | 34 | |
| 11 | 1999 | 24 | |
| 12 | 2005 | 19 | |
| 13 | 2009 | 16 | |
| 14 | 2018 | 15 | |
| 15 | 1999 | 15 | |
| 16 | 2004 | 11 | |
| 17 | 1997 | 8 | |
| 18 | 1998 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2021 | 6 |
About Mark Taylor
Mark Taylor is a scholar working on Molecular Biology, Spectroscopy, Organic Chemistry, Nephrology and Atomic and Molecular Physics, and Optics, having authored 39 papers that have together received 936 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Advanced Chemical Physics Studies (6 papers), Parathyroid Disorders and Treatments (6 papers), Chemical Reaction Mechanisms (6 papers), Mass Spectrometry Techniques and Applications (5 papers), Analytical Chemistry and Chromatography (4 papers), Free Radicals and Antioxidants (4 papers) and Spectroscopy and Quantum Chemical Studies (4 papers). The work is most often cited by research in Nephrology (168 citations), Genetics (81 citations), Molecular Biology (441 citations), Spectroscopy (95 citations) and Physical and Theoretical Chemistry (49 citations). Mark Taylor has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Wolfgang R. Dostmann, Werner Tegge, Christian K. Nickl, Ronald Frank, Joseph E. Brayden, Felician Muntean, Anne B. McCoy, W. C. Lineberger, Leo Radom and Alejandra González‐Duarte. Their work appears in journals such as The Journal of Chemical Physics, Neurology, Amyloid, The Journal of Physical Chemistry A and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.